Possible biological mechanisms for the impact of TMZ on the prolonging survival of GBM patients could be explained by the drug-related alkylation of DNA which interferes with GBM cell DNA replication, the depletion of MGMT repair enzyme activity [37], [38] or methylation of the MGMT promoter [5] after receiving the RT-TMZ. This evidence concerns the gene MGMT and glioblastoma.